Discovery of Pyrazolopyrazines as Selective, Potent, and Mutant-Active MET Inhibitors with Intracranial Efficacy
-
Published:2024-08-01
Issue:16
Volume:67
Page:14466-14477
-
ISSN:0022-2623
-
Container-title:Journal of Medicinal Chemistry
-
language:en
-
Short-container-title:J. Med. Chem.
Author:
Bumpers Quinn A.1ORCID, Pipal Robert W.1, Benz-Weeden Anna M.1, Brewster James T.1ORCID, Cook Adam1, Crooks Amy L.1, Cruz Cole1, Dwulet Natalie C.1, Gaudino John J.1, Golec Daniel1, Harrison Jacqueline A.1, Hartley Dylan P.1, Hassanien Sherif H.1, Hicken Erik J.1ORCID, Kahn Dean1ORCID, Laird Ellen R.1, Lemieux Christine1, Lewandowski Nicholas1, McCown Joseph1, McDonald Matthew G.1, McNulty Oren1, Mou Tung-Chung1, Nguyen Phong1, Oko Lauren1, Opie Lisa Pieti1, Otten Jennifer1, Peck Spencer C.1, Polites Viktor C.1, Randall Samuel D.1, Rosen Rachel Z.1, Savechenkov Pavel1, Simpson Helen1, Singh Anurag1, Sparks Drew1, Wickersham Kyle1, Wollenberg Lance1, Wong Christina E.1, Wong Jim1, Wu Wen-I1, Elsayed Mohamed S. A.1ORCID, Hinklin Ronald J.1ORCID, Tang Tony P.1
Affiliation:
1. Pfizer Research & Development 3200 Walnut Street, Boulder, Colorado 80301, United States
Publisher
American Chemical Society (ACS)
|
|